share_log

Nautilus Biotechnology Q1 2024 GAAP EPS $(0.15) Beats $(0.17) Estimate

Benzinga ·  Apr 30 07:06

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 25 percent decrease over losses of $(0.12) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment